PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease ReportsPeripheral vascular diseases
MeSH D016491 - peripheral vascular diseases
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D014652:Vascular diseases
1 Company
1 Drug
$
Success rate
D016491: 
Peripheral vascular diseases
45 Companies
23 Drugs
$
Success rate
D004916:Erythromelalgia
0 Companies
0 Drugs
Success rate
D010689:Phlebitis
0 Companies
0 Drugs
Success rate
D011928:Raynaud disease
31 Companies
5 Drugs
$
Success rate
D018438:Blue toe syndrome
0 Companies
0 Drugs
Success rate
D054068:Livedo reticularis
0 Companies
0 Drugs
Success rate
D058729:Peripheral arterial disease
4 Companies
2 Drugs
$
Success rate
D062108:May-thurner syndrome
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaCilostazol Cilostazol  2005-03-01   
Clopidogrel Clopidogrel Teva (hydrogen sulphate)  2009-07-27   
Clopidogrel Clopidogrel Teva Pharma (previously Clopidogrel HCS)  2009-09-21   
Clopidogrel Clopidogrel ratiopharm  2015-02-18   
Niacin Niacin  1982-01-01   
Clopidogrel Clopidogrel Teva Generics B.V  2010-10-28   
Clopidogrel Clopidogrel Teva Pharma B.V  2011-06-16   
Rising PharmaceuticalsCilostazol Cilostazol  2006-04-20   
Niacin Niacin  2019-02-22   
MylanClopidogrel Clopidogrel DURA  2009-07-21   
RocheFolic acid, Dexpanthenol, Ascorbic acid, Cyanocobalamin, Ergocalciferol, Vitamin a, Biotin, Niacinamide, Pyridoxine, Riboflavin, Thiamine Berocca Pn  1985-10-10   
Chartwell PharmaceuticalsNiacin Niacin  2014-03-20   
Cilostazol Cilostazol  2012-09-24   
SandozFolic acid, Dexpanthenol, Ascorbic acid, Cyanocobalamin, Vitamin a, Alpha-tocopherol, Biotin, Cholecalciferol, Niacinamide, Pyridoxine, Riboflavin, Thiamine, Tocopherol Infuvite  2000-05-18   
Niacin Niacin  1982-01-01   
AbbVieNiacin Niaspan Titration Starter Pack  1997-07-28   
AstraZenecaTicagrelor Brilique  2010-12-03   
Ticagrelor Possia  2010-12-03   
1
2
3
4
5
>
Clinical Trials
Historical Success Rate
Phase 1
57%
4/7
Phase 2
65%
13/20
Phase 3
35%
12/34
Approved: 6Overall Success rate: 13%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
Cilostazol,
Clopidogrel
Mylan
Clopidogrel,
Epoprostenol
GSK
Epoprostenol
Roche
Folic acid,
Dexpanthenol,
Ascorbic acid,
Cyanocobalamin,
Ergocalciferol,
Vitamin a,
Biotin,
Pyridoxine,
Riboflavin,
Inclacumab,
Dalcetrapib
AstraZeneca
Ticagrelor
Novartis
Gdmt
Sanofi
Clopidogrel,
Niacin,
Niacinamide,
Salicylic acid,
Riferminogene pecaplasmid,
Ancrod,
Sodium chloride,
Sodium lactate,
ATACIGUAT,
Microcrystalline cellulose,
Pbs,
Vp16
1
2
3
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use